INTRODUCTION
Although the tests could be done at any site, the proximal part of the flexor aspect of the forearm is Intradermal tests are widely used to support the conventionally used. This site can be conveniently diagnosis of dermatological and nondermatological exposed and the skin of the proximal area is more diseases. They are mainly indicated for the detection sensitive than the distal. of immediate (Type I hypersensitivity) and delayed type hypersensitivity (DTH, Type IV hypersensitivity)
INTERPRETATION OF INTRADERMAL TESTS towards exogenous or endogenous antigens. Intradermal tests for the diagnosis of infectious
The optimal time for reading the reaction depends diseases in relevance to dermatovenereology are upon the pharmacological agent used for the test discussed in this section. and the type of immunological reaction to be observed. Intradermal tests for the detection of DTH Intradermal tests for the diagnosis of infectious are read at 48h, although they can be read as early diseases are listed in Table 1 . They are indicated to as 12h and as late as four days. (The lepromin test detect DTH to organisms or their antigens.
is read at four weeks and depends on the formation of a granuloma, which is a measure of cell-mediated Before undertaking intradermal test, it is advisable to immunity.) The size of the induration is more stop or avoid systemic steroids or immunosuppressive important than erythema while interpreting Type agents at least three days before the procedure as IV hypersensitivity. moderate to large doses of corticosteroids may inhibit a DTH reaction.
PROCEDURE
The uniform feature of all intradermal tests is the injection of the antigen into the superficial layer of the dermis through a fine-bore (26 or 27-G) needle with its bevel pointing upwards. The quantity injected may vary from 0.01 to 0.1 ml but conventionally 0.1 ml is universally used.
Some of the commonly used intradermal tests in dermatovenereology are briefly discussed here.
INTRADERMAL TESTS FOR BACTERIAL INFECTIONS
Tuberculin test [1] [2] [3] [4] [5] Tuberculin test, also known as Pirquet's test/reaction or scarification test, was used by von Pirquet in 1907. The antigen used, tuberculin, is a purified protein extract of bacilli grown on 5% glycerol broth. One tuberculin injected for the first test has a booster effect tuberculin unit is injected intradermally on the flexor on the subsequent dose. aspect of the forearm and a reading taken after 48h (Mantoux method).
Tuberculins from atypical environmental bacteria have also been prepared. Induration measuring more than 10 mm in diameter They include PPD-B for Battey mycobacteria, PPD-Y is considered to be a positive response while that for M. kansasii, scrofulin for M scrofulaceum and burulin measuring less than 5 mm is considered as negative.
for M. ulcerans. A positive test indicates past or present infection with M. tuberculosis or vaccination with bacillus CalmetteLepromin test [6, 7] Guerin (BCG); an induration of more than 15 mm is It is a prognostic test that is very helpful in classifying usually not due to BCG vaccination. A positive test leprosy. It cannot be used for diagnostic purpose since does not indicate active infection except in children it is positive in a significant number of normal people younger than two years. Readings between 6 mm and and is negative towards the lepromatous pole of the mycobacteria or 9 mm are doubtful and could be because of an atypical mycobacterial infection. 
Leprosy
Frei's test [8] In India, lepromin antigen is prepared by the Central (Sterne strain), consists mainly of a complex of Teaching and Research Institute, peptidoglycans and polysaccharides. Chengalpattu, Tamil Nadu.
Anthraxin is prepared by using a cell wall extract in place of the vaccine antigen. Therefore, the anthraxin was developed in 1925 for skin test can differentiate between exposed and lymphogranuloma venereum (LGV) and uses Frei's unexposed individuals, even if they have been antigen. It indicates delayed hypersensitivity to an immunized. intradermal standardized antigen prepared from chlamydia grown in the yolk sac of a chick embryo.
The anthraxin skin test becomes positive in most of The test is read after 48h and again on the fourth the cases (80%) in the first three days of the disease, day. A nodule more than 5mm at fourth day is and stays positive for a long time after recovery from considered a positive response. the disease. Thus, the anthraxin skin test appears to be a valuable method for early diagnosis of acute A positive test indicates past or present chlamydial anthrax and is the only method for the retrospective infection. Frei's test becomes positive two to eight diagnosis of human anthrax. weeks after infection. Frei's antigen is common to all chlamydial species and is not specific to LGV. Due to Foshay test [11] its nonspecific nature, the test is no longer used. The test involves intradermal injection of a suspension of killed Bartonella henselae, the causative agent of catIto Reenstierna test scratch disease. The antigen is prepared from the Also known as Ducrey's test, this test was developed sterile lymph node material obtained from a patient to detect hypersensitivity against Haemophilus ducreyi, of cat-scratch disease.
Frei's test the causative organism of chancroid. A response indicates cell-mediated hypersensitivity against H. ducreyi and is due to past or current infection with the organism. The antigen is not commercially available.
Anthraxin test [9, 10] The anthraxin skin test, which measures DTH to anthrax antigens, has been used as a diagnostic tool. It has also been recommended by the WHO for evaluation of immunological memory against anthrax. Anthraxin, a cell wall extract from the vegetative, noncapsulated strain of B. anthracis
The appearance of an area of erythema more than 5 mm diameter after 48h at the injection site is considered a positive reaction. A positive test is a sign of past or present infection. The test is of historical importance only, as it is no longer used for diagnosis because of concerns about the transmission of the organism.
Dick's test
This test was devised in 1924 to identify children susceptible to scarlet fever, but is of historical value as scarlet fever is no longer a common or serious disease. The antigen used is pyrogenic exotoxin or Dick's or scarlatinal toxin of Streptococcus pyogenes. It is also known as erythrogenic toxin because intradermal injection causes an erythematous reaction in a susceptible person. About 0.1 cc of the toxin in the dilution of 1:1000 is injected intradermally on the forearm and the response is read after 24h.
The reaction is considered positive when there is an erythema more than 5 mm in diameter and strongly
The test dose of 0.1 mL (Candin ® Allermed Laboratories, Inc., San Diego, California) is injected intradermally on the forearm intended to elicit an induration response in excess of 5 mm at 48h after injection in immunocompetent persons with cellular hypersensitivity to the antigen.
Coccidioidin test [17, 18] There are two antigens available: coccidioidin and spherulin. Coccidioidin is prepared from autolysates positive if induration also develops. A positive of the mycelial phase (saprophytic phase) of reaction develops after 8-12h and reaches its
Coccidioides immitis, and spherulin, a more sensitive maximum after 24h. It is negative in convalescent reagent, from the spherule phase (parasitic phase [12, 13] diseases like tuberculosis and malignancies. The test This test is performed to detect allergic hypersensitivity is negative in patients with disseminated disease or in towards dermatophytes. Trichophytin antigen is a patients with thin-walled cavities. glycopeptide extracted (using acetone-ethylene glycol extraction method) from the spores and mycelia of Histoplasmin test [19] [20] [21] dermatophytes, mostly Trichophyton mentagrophytes. Histoplasmin skin testing is useful in epidemiological studies, such as investigations of case cluster or the Trichophytin in the concentration of either 10 µg, 1 µg definition of endemic areas but is not predictive of or 0.1 µg in 0.1 ml of normal saline is injected
histoplasmosis. An antigen containing the M and H intradermally into the flexor forearm. The test is read precipitins of Histoplasma capsulatum tends to elicit after 20 min for an immediate reaction and after 24 both immediate and delayed hypersensitivity, and or 72h for a delayed response. Erythema, edema or hence more false-positive reactions. An antigen that induration may be seen and a papulovesicular or is deficient in the M component can reduce this ulcerative lesion can also occur. A wheal larger than problem. 10 mm in diameter at 20 min and induration more than 5 mm at 72h is considered a positive response.
INTRADERMAL TESTS FOR PARASITIC INFECTIONS
Candidin test [14] [15] [16] Hypersensitivity towards Candida albicans is universal. Hence, a test cannot be used to diagnose the infection. The candidin test serves as an aid to evaluate the cellular immune response in patients suspected of having reduced CMI. Candidin is used as a recall antigen for detecting DTH by intradermal testing. Candidin is made from the culture filtrate and cells of two strains of Candida albicans. Compared with healthy controls, reactivity to candidin is significantly reduced in patients with AIDS, and patients with Hodgkin's disease or sarcoidosis (tuberculin sensitivity is more reliable in the latter case).
Leishmanin test (Montenegro test) [22] [23] [24] The first study of this test in humans was carried out by Montenegro in 1926 in Brazil. Leishmanin, which is provided by the Pasteur Institute of Teheran, Iran, contains killed Leishmania.
A positive reaction consists of a palpable nodule more than 5 mm in diameter developing in 48 to 72h and indicates DTH, but not necessarily immunity, to leishmania organisms. The test is not species-specific. It becomes positive early in the course of cutaneous or mucocutaneous leishmaniasis (except in diffuse cutaneous leishmaniasis) and only after recovery from visceral leishmaniasis. It is highly sensitive for cutaneous leishmaniasis.
It is a useful and important tool for epidemiological, immunological, and diagnostic studies and is an essential component of vaccine trials. However, it cannot distinguish between present and past infection.
